Research on Pharmaceutical Tax Management Issues in the Digital Economy

Abstract

Listen

Translate article

In the era of the digital economy, the deep integration of information technology with the pharmaceutical industry has become a new engine for innovation and development in the pharmaceutical sector. However, the integration of the pharmaceutical industry faces a series of challenges, such as difficulties in the identification of tax elements, asymmetry of tax-related information, low levels of informatization in pharmaceutical enterprises, insufficient information technology capabilities in tax authorities, and incomplete policies and regulations in the pharmaceutical industry, which constrain the healthy development of pharmaceutical companies. Against the backdrop of modern tax governance reform, the pharmaceutical industry urgently needs to strengthen tax management to adapt to new changes. Firstly, tax authorities need to leverage information technology to innovate and transform the systems of tax law enforcement, services, and regulation. Secondly, pharmaceutical companies need to use information technology to solidify their management foundations and enhance their capabilities and skills. Lastly, tax laws and policies related to the pharmaceutical industry need to be adjusted and improved in a timely manner to meet the new requirements of the digital transformation in the pharmaceutical sector. With the joint efforts of all parties, support and protection can be provided for the healthy development of the pharmaceutical industry. 在数字经济时代，信息技术与医药产业的深度融合，已成为推动医药行业创新和发展的新引擎。然而，医药产业融合发展过程中面临一系列挑战，税收要素认定困难、涉税信息不对称、医药企业信息化水平不高、税收部门信息化征管能力不足、医药行业政策法规不健全等，制约医药企业健康发展。在税收治理现代化改革背景下，医药行业亟需加强税收管理以适应新变化。首先税务机关需要利用信息技术，实现税务执法、服务、监管制度的创新和变革。其次医药企业需要运用信息化手段，夯实管理基础，提升能力与本领。最后医药税收法规政策需要与时俱进的调整与完善，以适应医药行业数字化转型的新要求。在多方共同努力之下，为医药行业的健康发展提供支持和保障。